Thomas P. Slavin

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots””.

Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots”

Genetics in Medicine(2020)10.1038/s41436-019-0740-6

N/A

0DataRank · unranked

64 citations

Brian H. Shirts, Thomas P. Slavin, Tom Walsh, Mary‐Claire King, Douglas M. Fowler +2 more

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients

BMC Cancer(2020)10.1186/s12885-020-07476-y

N/A

0DataRank · unranked

17 citations

Vivian Y. Shin, Cecilia Y.S. Ho, Chun Hang Au, Thomas P. Slavin, Jeffrey N. Weitzel +3 more

A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers

Cancer Research(2020)10.1158/0008-5472.can-20-1390

N/A

0DataRank · unranked

28 citations

Emília M. Pinto, Thibaut Barnoud, Jessica C. Leung, Tetyana Martynyuk, Andrew V. Kossenkov +31 more

Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants

medRxiv(2020)10.1101/2020.04.25.20078931

N/A

0DataRank · unranked

5 citations

Kristy Lee, Magali Olivier, Tina Pesaran, Phuong L. Mai, Kelvin C. de Andrade +18 more

Clinical conundrums: Developing a strategy for discerning TP53-associated chip and coherent clinical care.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1514

N/A

0DataRank · unranked

1 citations

Judy E. Garber, Danielle Castillo, Sharon Sand, Rosa Mejia, Aleck Cervantes +9 more

Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative

Cancer(2021)10.1002/cncr.33767

N/A

0DataRank · unranked

55 citations

Elisha Hughes, Timothy Simmons, Ryan Bernhisel, Braden Probst, Stephanie Meek +13 more

Multigene assessment of genetic risk for women for two or more breast cancers

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06201-y

N/A

0DataRank · unranked

7 citations

John Kidd, Ryan Bernhisel, Susan Shehayeb, Paul Frankel, Kathleen R. Blazer +12 more

Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1296

N/A

0DataRank · unranked

11 citations

Tze‐An Yuan, Bita Nehoray, Aleck Cervantes, Kevin K. Tsang, Kai Yang +11 more

Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma

Cancers(2023)10.3390/cancers15020528

N/A

0DataRank · unranked

1 citations

Pamela Peters, Regina S. Whitaker, Shonagh Russell, Benjamin B. Albright, Shelly Cummings +6 more